Telix Pharmaceuticals (TLPPF) Debt Ratio (2023 - 2026)

Telix Pharmaceuticals (TLPPF) has reported Debt Ratio for 4 consecutive years, with 0.38 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.38 in Q2 2026; TTM through Jun 2026 was 0.38, a N/A change from a year earlier, with the FY2025 full-year figure at 0.35, down 12.34% from the prior year.
• Debt Ratio was 0.38 for Q2 2026 at Telix Pharmaceuticals, up from 0.35 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.38 in Q2 2026 and troughed at 0.02 in Q4 2023.
• A 4-year average of 0.28 and a median of 0.36 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio soared 1565.86% in 2024 and dropped 7.56% in 2025, its largest moves.
• Over 4 years, Debt Ratio stood at 0.02 in 2023, then jumped by 1565.86% to 0.38 in 2024, then slipped by 7.56% to 0.35 in 2025, then gained by 8.97% to 0.38 in 2026.
• The last three Debt Ratio figures came in at 0.38 (Q2 2026), 0.35 (Q4 2025), and 0.38 (Q4 2024), per Business Quant data.